Oncotherics
OncoTherics is a new pharmaceutical company, focusing on the development of novel hypoxia-activated pro-drugs for the treatment of a wide range of cancers. The company was formed as a spin-out from BioStatus, to progress a novel small molecule, code-named OCT1002. The company is at an early stage but the patented technology has a unique history allowing a more rapid than usual progression through the clinical trial process. For further information, please contact us using the contact form provided on this site.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Oncotherics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Oncotherics
1 distinct titles indexed · top 1 shown.
- 1chief medical officer
Sign up to unlock all 2 contacts at Oncotherics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Oncotherics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.